All In Biotech

Drug Trial Radar · NCT05289947

MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients With Stroke

Last checked: Nov 19, 2026Latest source record: Dec 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 303 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

303

Actual

Start

Jul 21, 2023

Primary completion

Jul 18, 2025

Study completion Jul 18, 2025

Sponsor

Lead sponsor
Moleac Pte Ltd.Industry
Sponsor type
Industry
First posted
Mar 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, double-blind, placebo-controlled trial of MLC1501 in patients with stroke. Eligible participants will be randomized in a 1:1:1 ratio to orally receive MLC1501 high-dose twice a day, MLC1501 low-dose twice a day, or matching placebo for 24 weeks.

Conditions

  • Stroke
  • Stroke, Ischemic
  • Strokes Thrombotic
  • Stroke Sequelae
  • Stroke, Cardiovascular
  • Stroke, Embolic
  • Stroke, Cryptogenic

Interventions

  • PlaceboOther

    Caramel, chocolate brown, flavor (E\_1982648), dextrin

  • MLC1501Drug

    Powdered extract of Radix astragali, Rhizoma chuanxiong, Radix angelica sinensis, Radix polygala

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Fugl-Meyer motor Assessment (FMA)Time frame: 24 weeks

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Baguio General Hospital and Medical Center

    Baguio City, Philippines

  • West Visayas State University Medical Center

    Iloilo City, Philippines

  • Jose R. Reyes Memorial Medical Center

    Manila, Philippines

  • Manila Doctors Hospita

    Manila, Philippines

  • Metro Davao Medical And Research Center

    Davao City, Davao Region, Philippines

  • Quirino Memorial Medical Center

    Manila, Manila, Philippines

  • University of Santo Tomas Hospital

    Manila, Manila, Philippines

  • Raffles Hospital

    Singapore, Singapore

  • Singapore General Hospital

    Singapore, Singapore

  • Changi General Hospital

    Singapore, Singapore, Singapore

  • National Neuroscience Institute (NNI) @ Tan Tock Seng Hospital (TTSH)

    Singapore, Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.